British Journal of Medical & Surgical Urology
Volume 3, Issue 2 , Pages 52-58, March 2010

The problems of gelatine and prescribing urologically specific medication to a diverse population in the UK. An initial study

  • Hazel E. Warburton

      Affiliations

    • The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, United Kingdom
    • Corresponding Author InformationCorresponding author. Present address: Highfield Stables, Weaste Lane, Thelwall, Warrington, WA4 3JP, United Kingdom. Fax: +44 0161 276 4221.
  • ,
  • Mark S. Payne

      Affiliations

    • Leeds Partnerships NHS Foundation Trust, Twenty One Fifty, Thorpe Park, Leeds, LS15 8ZB, United Kingdom
  • ,
  • Stephen R. Payne

      Affiliations

    • Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL, United Kingdom

Received 9 August 2009; received in revised form 18 October 2009; accepted 27 October 2009.

Summary 

Introduction

Gelatine is a setting agent used by the food and drug industries whose consumption is forbidden by religious and other faith groups. Gelatine-containing drugs are found in most of the drug classifications in Section 7.4 of the British National Formulary (BNF). We investigate the issues and seek to provide a solution to the use of gelatine-containing medications in urology.

Methods

Forty representative urological practitioners were surveyed to ascertain if they knew of gelatine-containing urological drugs, had encountered patients enquiring about gelatine-containing medication, and where they would seek this information from.

Results

Twenty-five percent of surveyed urologists had experience of patients refusing medication on the suspicion of gelatine content. 53% were unsure if urological drugs could contain gelatine, while 22%, wrongly, thought they did not. Regarding acquisition of drug constituent information, approximately a third did not know, a third looked to incorrect resources and a third referred to their pharmacy's drug information service.

Conclusion

Most urologists are unaware of the issues surrounding the prescribing of gelatine-containing urological medications, the most important being those given for the management of prostatic hypertrophy. A knowledge of alternative prescribing options can help avoid belief violation for our diverse community in the UK.

Keywords: Gelatine, Urological medication, Porcine, Bovine, Ethics, Consent

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1875-9742(09)00184-0

doi:10.1016/j.bjmsu.2009.10.005

British Journal of Medical & Surgical Urology
Volume 3, Issue 2 , Pages 52-58, March 2010